News | August 26, 2025
Merck will share two oral presentations on ASCVD treatment patterns and patient burden
Investment supports Company’s plans to manufacture the vast majority of advanced medicines in the U.S. to meet the needs of patients in the U.S.
The agreement complements other PPAs for Sandoz production sites globally
These filings come after FDA issued its latest warning to patients and healthcare professionals about the serious dangers of compounded GLP-1 drugs
he new version features a streamlined sample-to-analysis workflow, built-in HRD detection, faster turnaround, and lower tissue requirements
NewCo’s pipeline includes five investigational medicines
The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters
Roche also shared the design of its upcoming Phase III TRONTIER 1 and 2 trials investigating trontinemab in people with early symptomatic Alzheimer’s disease
Enables additional US manufacturing capacity to serve increased demand for pharma/biotech customers
Subscribe To Our Newsletter & Stay Updated
